Kindlin-2 Inhibits TNF/NF-κB-Caspase 8 Pathway in Hepatocytes to Maintain Liver Development and Function

Huanqing Gao,Yiming Zhong,Liang Zhou,Sixiong Lin,Xiaoting Hou,Zhen Ding,Yan Li,Qing Yao,Huiling Cao,Xuenong Zou,Di Chen,Xiaochun Bai,Guozhi Xiao

DOI: https://doi.org/10.7554/elife.81792

IF: 7.7

2023-01-01

eLife

Abstract:Inflammatory liver diseases are a major cause of morbidity and mortality worldwide; however, underlying mechanisms are incompletely understood. Here we show that deleting the focal adhesion protein Kindlin-2 expression in hepatocytes using the Alb-Cre transgenic mice causes a severe inflammation, resulting in premature death. Kindlin-2 loss accelerates hepatocyte apoptosis with subsequent compensatory cell proliferation and accumulation of the collagenous extracellular matrix, leading to massive liver fibrosis and dysfunction. Mechanistically, Kindlin-2 loss abnormally activates the tumor necrosis factor (TNF) pathway. Blocking activation of the TNF signaling pathway by deleting TNF receptor or deletion of Caspase 8 expression in hepatocytes essentially restores liver function and prevents premature death caused by Kindlin-2 loss. Finally, of translational significance, adeno-associated virus mediated overexpression of Kindlin-2 in hepatocytes attenuates the D-galactosamine and lipopolysaccharide-induced liver injury and death in mice. Collectively, we establish that Kindlin-2 acts as a novel intrinsic inhibitor of the TNF pathway to maintain liver homeostasis and may define a useful therapeutic target for liver diseases.